RT Journal
A1 Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R
T1 PAtient preferences for deactivation of implantable cardioverter-defibrillators
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD March 11
VO 173
IS 5
SP 377
OP 379
DO 10.1001/jamainternmed.2013.1883
UL http://dx.doi.org/10.1001/jamainternmed.2013.1883
AB 
While implantable cardioverter-defibrillators (ICDs) prolong life, painful shocks can occur at the end of life, and physicians rarely discuss the option of device deactivation.1- 2 To prevent shocks at the end of life that do not meaningfully prolong survival, a recent Heart Rhythm Society consensus statement recommended proactive communication with patients regarding deactivation.3 However, most surveys have found that the majority of ICD patients would not consider deactivation even in deleterious future health states including terminal cancer,4 constant dyspnea,5 or frequent shocks.5- 6